Molecular Response to Imatinib and Its Correlation with mRNA Expression Levels of Imatinib Influx Transporter (OCT1) in Indian Chronic Myeloid Leukemia Patients

Background and objectives:

Imatinib mesylate is approved for the treatment of Chronic Myeloid Leukemia (CML). About 20% of patients with CML do not respond to treatment with Imatinib either initially or because of acquired resistance. In addition to mutated BCR-ABL1 kinase, the organic cation transporter1 (OCT1, encoded by SLC22A1) has been considered to contribute to Imatinib resistance in patients with chronic myeloid leukemia (CML). OCT1 has been reported to be the main influx transporter involved in Imatinib uptake into CML cells. To date, only a few studies have been reported on involvement of influx transporters in development of Imatinib resistance. Therefore this study was aimed to determine the expression level of Imatinib uptake transporter (OCT1) in CML patients and to correlate this level with molecular response.

Methods:

One hundred fifty eight patients on Imatinib were considered for gene expression analysis study for OCT1 gene. Total RNA was extracted from peripheral blood mononuclear cells. Complementary DNAs (cDNAs) were synthesized and Real Time Polymerase Chain Reaction (RQ-PCR) was performed.

Results:

High OCT1 expression was present in 81 (51.8%) patients and low OCT1 expression was in 77 (48.7%) patients. Low Sokal risk score group have a significantly high OCT1 expression (p=0.048). The rate of molecular response was higher in those with high OCT1 expression than in those with low OCT1 expression (p=0.05). Both event-free survival and median overall survival were significantly shorter in patients with low OCT1 expressions when compared to the patients with high OCT1 expression (p=0.03 and p=0.05).

Conclusions:

Our findings demonstrated that the mRNA expression level of OCT1 was significantly correlated with molecular response in CML patients. Based on these findings, present study believes that the pre-therapeutic higher expression of OCT1 may help to predict response to imatinib therapy in CML patients.

Prognostic relevance of aberrant SOCS-1 gene promoter methylation in myelodysplastic syndromes patients

INTRODUCTION

The inactivation of suppressor of cytokine signaling SOCS-1, a negative regulator of cytokine pathways, by hypermethylation was shown in hematological malignancies including Myelsplastic Syndromes. So far, its prognostic relevance in myelodysplastic syndromes (MDS) patients has not been understood.

METHODS

Methylation status of SOCS-1 gene was analyzed in series of 100 patients using methylation-specific PCR (MS-PCR) and correlated with disease severity, progression, and survival by comparing prognostic factors such as hematological, clinical, and cytogenetics.

RESULTS

Of the total of 100 MDS patients analyzed, methylation of SOCS1 gene was found in 53% patients. Also, the frequency of patients with poor and intermediate cytogenetics was observed significantly high in methylated group (P < 0.001). Moreover, the patients with methylated SOCS-1 gene had significantly more frequent disease progression as compared to the patients with unmethylated SOCS-1 gene (P < 0.006). Both progression-free survival and median overall survival were significantly shorter in patients with methylated SOCS-1 gene when compared to the patients with unmethylated SOCS-1 gene (P = 0.006 & P = 0.001, respectively).

CONCLUSION

This study for the first time showed that the mathylation of SOCS-1 gene plays an important role in the disease progression and is associated with poor survival especially among the high-risk patients. This may be due to high association between SOCS1 methylation and higher risk subtypes of MDS (such as RAEB) in this study.

Chromium (VI) biosorption by immobilized Aspergillus niger in continuous flow system with special reference to FTIR analysis

Aspergillus niger was treated with acid and immobilized in calcium alginate matrix. The dynamic removal of Cr (VI) ion was studied using continuously fed column packed with immobilized biosorbent beads. Column experiments were carried out to study the effect of various bed heights (20, 30, 40 cm) under different flow rates (5, 7.5, 10 ml min(-1)) on efficiency of biosorption. The maximum time (1020 minutes; 17 hr) before breakthrough point was observed in case of 40 cm bed height with flow rate of 5ml min(-1). FTIR analysis of acid treated immobilized A. niger was used fora qualitative and preliminary analysis of chemical functional groups present on its cell wall which provided the information on nature of cell wall and Cr (VI) interaction during the process of biosorption. The IR spectra of biosorbent recorded before and after chromium biosorption had shown some changes in the band patterns, which were finally analyzed and was found that chemical interaction such as ion-exchange between carboxyl (-COOH), hydroxyl (-OH) and amine (-NH2) group of biosorbent and Chromium ion were mainlyinvolved in biosorption of Cr (VI) onto A. niger cell wall surface. The biosorbed metal was eluted from biosorbent by using 0.1 M H2SO4 as eluant. Immobilized biosorbent could be reused for five consecutive biosorption and desorption cycles without apparent loss of efficiency after its reconditioning. Considering all above factors together this paper discusses the efficient chromium biosorption process carried out by immobilized A. niger biosorbent.

Biosorption of Cr (VI) ions from electroplating industrial effluent using immobilized Aspergillus niger biomass

A fungus, Aspergillus niger was chemically treated with 0.1 M H2SO4 and 0.1 N NaOH to form biosorbent and it was immobilized in calcium alginate beads. The biosorption capacity of immobilized biosorbents for Cr (VI) was found to depend on pH, contact time, biosorbent dose and initial concentration of Cr (VI). The maximum uptake of Cr (VI) was 92.5, 95.9 and 98.4 mg respectively at a pH of 1.5 and with an increase in pH up to 10.5 the metal uptake decreased gradually up to 38.75, 50.19 and 65.28 mg respectively for acid treated, untreated and base treated fungal biosorbents. Increase in biosorbent dose up to 1 g of biomass and contact time up to 60 min resulted in an increase in biosorption from 19.6, 15.6 and 26.1 mg at a biosorbent dose of 0.1 g 100 ml(-1) to 92.45, 95.7 and 98.52 mg at a biosorbent dose of 1.0 g 100 ml(-1) and then further increase in adsorbent dose and contact time did not resulted in more Cr (VI) adsorption by per unit weight of biosorbent. The value of Kad (adsorption rate constant) revealed the pseudo-first order nature of biosorption. The percentage metal uptake by the biosorbent was found to decrease upto 62.33, 52.67 and 83.5 percent respectively for acid treated, untreated and base treated fungal biosorbents at the 300 mgl(-1) Cr (VI) ion concentration. The resulted data was found to fit well in Langmuir model of adsorption isotherm with a high value of correlation coefficient. The value of Qmax, b (Langmuir constants), R(L) (separation factor) and delta G (Gibb's free energy) revealed the favourable nature of adsorption. The biosorbed metal was eluted from the biosorbent by using 0.1 M H2SO4 as elutant. Immobilized biosorbent can be reused for five consecutive biosorption/desorption cycles without apparent loss of efficiency after its reconditioning. The biosorbent was found to perform well in the electroplating industrial effluent.